DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
GnRH signaling pathway	R-HSA-168638	map04912	ranitidine	3001055	drug-path
MAPK signaling pathway	R-HSA-9652817	map04010	ranitidine	3001055	drug-path
Glioma	Q9NZM4	map05214	piroxicam	54676228	drug-path
Phosphatidylinositol signaling system	R-HSA-1280215	map04070	piroxicam	54676228	drug-path
Insulin signaling pathway	R-HSA-74752	map04910	piroxicam	54676228	drug-path
Long-term potentiation	R-HSA-9620244	map04720	piroxicam	54676228	drug-path
RNA polymerase	R-HSA-73864	map03020	piroxicam	54676228	drug-path
Glioma	Q9NZM4	map05214	norfloxacin	91536	drug-path
Graft-versus-host disease	R-HSA-1643685	map05332	norfloxacin	91536	drug-path
Olfactory transduction	R-HSA-9751605	map04740	norfloxacin	91536	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	norfloxacin	91536	drug-path
Prostate cancer	R-HSA-2990872	map05215	norfloxacin	91536	drug-path
Acute myeloid leukemia	R-HSA-9680350	map05221	norfloxacin	91536	drug-path
Melanoma	Q9UHD0-PRO_0000015379	map05218	norfloxacin	91536	drug-path
ErbB signaling pathway	R-HSA-168638	map04012	norfloxacin	91536	drug-path
Apoptosis	R-HSA-109581	map04210	norfloxacin	91536	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	viomycin	135398671	drug-path
Olfactory transduction	R-HSA-9751605	map04740	viomycin	135398671	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	viomycin	135398671	drug-path
Melanogenesis	R-HSA-5662702	map04916	viomycin	135398671	drug-path